SCHEMBL4753850

SCHEMBL4753850

NC(=O)N1C=Cc2ccccc2C=C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.50
LMNA P02545 2/20 0.50
MAPK1 P28482 1/20 0.50
SCN4A P35499 1/20 0.50
SCN5A Q14524 1/20 0.50
SCN9A Q15858 1/20 0.50
P2RX4 Q99571 9/20 0.40
MAPT P10636 2/20 0.36
HSD17B10 Q99714 2/20 0.36
POLB P06746 1/20 0.36
CYP3A4 P08684 1/20 0.36
PARP1 P09874 1/20 0.36
CYP2C19 P33261 1/20 0.36
RECQL P46063 1/20 0.36
BLM P54132 1/20 0.36
PMP22 Q01453 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
BCHE P06276 1/20 0.35
ACHE P22303 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2120774 0.79 P2RX4 (0.39) TSHRLMNAMAPK1SCN4ASCN5A
SCHEMBL4538395 0.77 MAPK1 (0.37) TSHRLMNAMAPK1SCN4ASCN5A
SCHEMBL15569871 0.74 TSHR (0.43) TSHRLMNAMAPK1SCN4ASCN5A
SCHEMBL4664953 0.72 NOTUM (0.39) TSHRLMNAMAPK1SCN4ASCN5A
SCHEMBL305168 0.69 HDAC3 (0.43) TSHRLMNAMAPK1SCN4ASCN5A
SCHEMBL6669756 0.69 MAPK1 (0.42) TSHRLMNAMAPK1SCN4ASCN5A
SCHEMBL5999468 0.69 LMNA (0.42) TSHRLMNAMAPK1SCN4ASCN5A
SCHEMBL1840637 0.67 LMNA (0.41) TSHRLMNAMAPK1SCN4ASCN5A
SCHEMBL3765842 0.67 LMNA (0.49) TSHRLMNAMAPK1SCN4ASCN5A
Hydrochloric Acid SCHEMBL7008280 0.67 HDAC3 (0.42) TSHRLMNAMAPK1SCN4ASCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017144393-A1 2-SUBSTITUTED 5-(PHENYL)-1,2-DIHYDRO-3H-3-BENZAZEPINE-3-CARBOXAMIDE DERIVATIVES AS BRD4 INHIBITORS FOR THE TREATMENT OF CANCER BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-08-31 WO claimed
WO-2008149163-A2 POTASSIUM ION CHANNEL MODULATORS AND USES THEREOF LECTUS THERAPEUTICS LIMITED (GB) 2008-12-11 WO claimed
WO-2017144393-A1 2-SUBSTITUTED 5-(PHENYL)-1,2-DIHYDRO-3H-3-BENZAZEPINE-3-CARBOXAMIDE DERIVATIVES AS BRD4 INHIBITORS FOR THE TREATMENT OF CANCER BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-08-31 WO disclosed
WO-2008149163-A2 POTASSIUM ION CHANNEL MODULATORS AND USES THEREOF LECTUS THERAPEUTICS LIMITED (GB) 2008-12-11 WO disclosed